Open-label, Randomised and Multi-center Study Evaluating the Efficacy and Safety of an Optimised Background Antiretroviral Regimen (OB) Compared to OB Associated With Enfuvirtide in Previously Treated HIV-1 Infected Patients in Virological Success After a 28-week Induction Treatment With Enfuvirtide Plus OB
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms INDEED
- Sponsors Roche
- 09 Nov 2008 Results were presented at the 9th International Congress on Drug Therapy in HIV Infection.
- 16 Apr 2008 Status changed from in progress to completed.
- 02 Jun 2006 New trial record.